Tirzepatide Grey: What Grey-Market Tirzepatide Is and Why It Matters (October 2026)

01 · The core answer

What grey tirzepatide means

Grey tirzepatide is tirzepatide obtained outside the licensed supply chain. It is usually sold online as a vial, a powder or a "research chemical", often with instructions to mix and measure at home. It has not been checked by a UK regulator, dispensed by a pharmacy or prescribed to you personally. That is why the market is called "grey": it sits between legitimate supply and outright fakes, and it is not safe to assume any given seller is on the right side of that line.

The phrase "going grey" simply describes the decision to buy this way, usually because the price looks lower or because someone has been told they do not qualify for treatment. First, the core fact. Tirzepatide is the active ingredient in Mounjaro, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ It is supplied as a pre-filled multi-dose KwikPen. Nothing about the licensed product involves a vial, a syringe you draw up yourself or a powder you dissolve.

There is no recognised grey version of the pen. If a seller offers an unbranded or relabelled pen, or one with no pharmacy label and no leaflet, treat it as a warning sign. Colour and appearance are not a reliable test of whether a product is genuine. The patient information leaflet describes the genuine product, and a regulated pharmacy will answer questions about where its stock comes from.¹³

02 · Your decision

Is this relevant to you, and what should you do next?

It is relevant if you have seen a very low price for tirzepatide on social media, a forum or a marketplace, or if you are weighing up a vial against a pen. The table sets out the differences in plain terms.

If you are tempted by grey supply, the practical next step is to price the regulated route properly. Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, checked 10 October 2026. Our starting Mounjaro pen costs £169.99 at the standard price. Every later order is £25 off the standard price. Our broader weight loss clinic page explains the full pathway, and the consultation is free and carries no obligation.

If you have already used grey supply, do not hide it. Tell the prescriber exactly what you took, when and in what amounts. That lets them advise you safely rather than guess.

Related guide: Grey glp 1.

03 · Grey market explained

Grey market explained: where the term comes from

A grey market is trade that is not strictly illegal in every detail but sits outside the official, regulated channel. For medicines, that matters far more than it does for handbags or electronics. A prescription medicine reaches you safely because a chain of controlled steps connects it to you: licensed manufacture, authorised distribution, pharmacy dispensing and a clinician who has decided the medicine suits you. Grey supply bypasses most or all of those steps.

With tirzepatide, the grey market usually involves the active ingredient sold as a powder or pre-mixed liquid in a vial, labelled for "research use" or "not for human consumption". That label is a legal workaround. It lets the seller avoid the rules that apply to medicines while the buyer injects the product anyway. Nobody in that chain has taken responsibility for the product being fit for injection into a person.

Compare that with Mounjaro, which is the brand name for tirzepatide made by Eli Lilly. The UK licence covers weight management in adults and type 2 diabetes, and the product is a pre-filled KwikPen in a fixed set of strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ A vial from an unknown seller is not the same product, even if the word tirzepatide appears on the label. It may contain the right substance, a different amount, a contaminated mixture or something else entirely, and you cannot tell by looking.

Counterfeit and unlicensed medicine alerts are published by the MHRA, which also runs the Yellow Card scheme for reporting side effects and suspect products.⁷ Those alerts exist because fake and unapproved versions of popular medicines are a recurring problem, and weight-loss injections are an obvious target given their popularity.

It also helps to separate three things people lump together. Grey-market supply is unlicensed material of unknown origin. Counterfeit supply is deliberately faked to look like the real brand. Compounded or "custom" supply is a mixture made to a seller's own recipe. They differ in detail, but for a buyer the consequence is the same: nobody can vouch for what is in the vial, and you carry all the risk.

Finally, there is a patent angle that confuses buyers. Some sellers argue that because tirzepatide is a molecule, anyone can sell it. Our guide on whether tirzepatide is patented covers why that reasoning does not make unlicensed injectables safe or legal to supply in the UK. Whatever the intellectual-property position, a medicine still needs a licence, a pharmacy and a prescriber before it reaches a patient.

04 · Vials versus KwikPens

Vials versus a licensed KwikPen: what actually differs

The biggest practical difference is who does the measuring. With a licensed pen, the manufacturer fills and calibrates the device and you simply dial the dose. With a vial, you or the seller decide how much liquid to draw into a syringe, usually from a powder that has to be reconstituted first. Every step is a chance for error, and the error is invisible until you feel unwell.

The Mounjaro KwikPen is set by turning the dose knob until the dose indicator shows the correct dose in the window. That built-in dose setting disappears when you move to a vial and syringe.

Injection technique is also standardised with a pen. Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food. Each KwikPen contains four weekly doses.¹ Follow the pen's instructions on how to hold it, rather than a video from a seller. Sites are the stomach area, the front of the thigh, or the back of the upper arm if someone else gives the injection, and you rotate the site with each dose.

Vials also raise questions that licensed pens answer for you. How long can the mixed liquid be kept? At what temperature? Is it still sterile after it has been pierced several times? A seller with no regulatory duty has no reason to answer honestly, and the answers printed on a vial label cannot be checked. By contrast, the pen's storage and in-use limits are set out in the leaflet and the product information.

Then there is the matter of strengths. Licensed Mounjaro comes in a defined ladder, which exists because the dose is built up gradually for tolerability. Grey sellers tend to describe doses in milligrams per vial and leave you to work out the rest, which makes it easy to jump to a much higher dose than a first-time user should take. This is the commonest way people get into trouble: not malice, but arithmetic done at a kitchen table.

None of this is a criticism of anyone who is curious or frustrated by cost. It is a reminder that the pen is not a luxury wrapper around the same thing. It is a medical device designed to take the dosing risk away from the user.

05 · Risks of grey supply

The risks of grey tirzepatide

The main risks are unknown contents, unknown dose, poor sterility and no clinical oversight. Each one matters on its own, and together they make grey supply a poor bargain even when the headline price is low.

Unknown contents. Without regulated manufacture and testing, there is no assurance that a vial contains tirzepatide at all, or only tirzepatide. UK regulators warn against buying prescription medicines from unverified sellers.⁷

Unknown dose. Even a pure product can be mislabelled, under-filled or over-filled. A dose that is much lower simply wastes your money and your time.

Sterility. A licensed pen arrives sealed and made to pharmaceutical standards. A home-mixed vial does not.

No oversight. A prescriber's role is not a formality. They check whether tirzepatide is suitable for you, what else you take and whether it should be stopped or adjusted. The commonest early effects of the licensed medicine are mild nausea, altered appetite and tiredness in the first days after each injection, and these usually settle.¹ A grey seller offers no one to call if your symptoms are different from that.

Grey supply is often paired with advice to take tiny or spread-out doses. Altering doses outside the licence means unknown dosing accuracy and no safety data.¹

No safety net. If you do have a problem on a licensed product, you can report it through the MHRA Yellow Card scheme and contact the pharmacy that dispensed it.¹⁹ With grey supply, there may be nobody to contact, and you may not know what to tell a doctor you are seeing in an emergency.

Financial risk. Some sellers simply take payment and never send anything. Payment by methods with weak buyer protection makes recovery harder. These scams thrive precisely because buyers feel unable to complain about something they were not meant to be buying.

If you notice severe, persistent stomach pain, swelling of the face, lips or throat, or difficulty breathing after using any injectable, get medical help straight away. For any other new symptom, speak to a doctor or pharmacist and tell them exactly what you used.

06 · Checking a seller

How to check whether a seller is legitimate

The quickest test is whether the seller appears on the GPhC register. The General Pharmaceutical Council keeps a public register of pharmacies and pharmacy professionals, and any genuine UK online pharmacy will show its registration number on its site.¹² Ours is GPhC 9012878, and you can look it up on the register yourself. Do not rely on a logo or badge alone. Search the register directly and check that the name and website match.

Next, look at how the seller handles the prescription. A legitimate pharmacy will not supply a prescription-only medicine without a consultation and a prescriber's decision. A seller offering to supply without a consultation or prescription is, by definition, not operating as a regulated pharmacy for that product. Our process is a free online consultation, a review by a GPhC-registered prescriber, dispensing by our registered pharmacy and a tracked delivery. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Look at the product language too. Phrases such as "research use only", "not for human consumption", "peptide" or "powder" next to a medicine name should end the conversation. So should promises of specific results, pressure to buy quickly, payment only by bank transfer or cryptocurrency, and a refusal to say who dispenses the product.

Ask where the stock comes from. We supply Mounjaro through official LillyDirect supply, which means direct from Eli Lilly's UK distribution, and the pens are genuine KwikPens. A seller who cannot say where their product originates is asking you to take their word for it.

Check what you receive. A licensed pen arrives with a pharmacy label, the patient information leaflet and instructions. Needles, a sharps bin and injection guidance are included with every order from us. If a package arrives with none of this, that is a red flag even if you have already paid.

Finally, check support. We provide support Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. Aftercare includes monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Repeat orders re-check suitability, and nothing ships automatically.

If you do suspect a counterfeit or unlicensed product, the MHRA publishes alerts and takes reports, and the Yellow Card scheme covers suspected side effects.⁷ Reporting helps protect other people.

07 · What it really costs

What regulated treatment really costs

Many people look at grey supply because they believe the licensed route is out of reach. The live figures suggest the gap is smaller than the headlines imply. Across the UK pharmacies we track, the cheapest and dearest Mounjaro pens cost £143.96 and £339.00 per month, depending on dose and provider, checked 10 October 2026. For the 2.5mg starting pen alone, the range is £143.96 to £179.99. The gap between providers for the same dose runs from £27 to £41, so shopping around within the regulated market is worthwhile.

At EverydayMeds, the standard price of the Mounjaro pen is £169.99 at 2.5mg, £218.99 at 5mg, £279.99 at 7.5mg, £290.99 at 10mg, £319.99 at 12.5mg and £329.99 at 15mg, per pen, checked 10 October 2026. A new customer's first order is £40 less at any dose with code FIRST40, including people switching to us at a higher dose. Every future order then carries an automatic £25 reorder discount (code DOSE25).

Planning over time is easier with the computed totals. The first four pens, using pens of 2.5mg, 5mg, 7.5mg and 10mg, cost £959.96 at standard prices. A first year costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg. Those figures are before discounts, so your first order is £40 less and each later order £25 less. If you settle at another strength, the monthly price for that dose is the figure to plan around.

Compare that with the real cost of grey supply. The low sticker price excludes the value of a clinical review, a sterile device, a reliable dose and recourse if something fails. It also excludes the risk that you pay and receive nothing, or something unusable. A product that might not work, or might harm you, is not cheap at any price.

Payment on the regulated route is flexible: Visa or Mastercard, Klarna and pay-monthly options are available, with no subscriptions. The consultation is free, and the price shown is the price paid with no hidden fees. Delivery is free next-day tracked in temperature-controlled packaging, with same-day dispatch when you order by 3pm. Saturday delivery is £14.99. Current availability is shown live: our doses are in stock.

08 · NHS and private routes

NHS and private routes: what is realistic

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions. Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴⁶

If you think you might qualify, your GP is the first conversation to have, and the NHS guide to tirzepatide explains what the medicine is used for and how it is prescribed.⁵ Being told you do not yet qualify on the NHS is not a reason to turn to unregulated supply. It is a reason to consider the regulated private route, where a prescriber still assesses whether treatment is suitable for you.

Private prescribing is not a loophole. The medicine is licensed for weight management in adults, and it is used alongside a reduced-calorie diet and increased physical activity. A GPhC-registered prescriber reviews each consultation, and unsuitable orders are declined and refunded automatically. That review is the part grey supply cannot replicate. It is also where interactions get caught. For example, people taking certain hormone medicines often ask whether anything needs to change, and our guide on estradiol and Mounjaro covers that question. Contraception is another area where the prescriber's advice matters, because Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. Switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.⁷

Insulin and sulfonylurea users also need a prescriber, because their doses may need adjusting to avoid low blood sugar. That is exactly the kind of individual detail a vial seller will never ask about.

Wegovy is another licensed option. NHS access to Wegovy runs through specialist weight-management services, so ask your GP. Privately, you can look at the Wegovy pen as an alternative to discuss with a prescriber. Which medicine suits you depends on your health, your preferences and your response, and a regulated consultation is the place to work that out.

The key point for anyone weighing grey supply is that you are not forced to choose between waiting years for the NHS and taking a risk with an unknown vial. A regulated middle route exists, with a real pharmacy, a real prescriber and a real pen.

09 · What licensed treatment looks like

What licensed treatment looks like in practice

Licensed treatment is a gradual, supervised process. Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. The dose then steps up no faster than after at least four weeks, towards a maximum of 15mg weekly, depending on how you respond and tolerate it. Many people settle at a maintenance dose of 5mg, 10mg or 15mg, and higher is not automatically better. Your prescriber guides the pace.¹

The mechanism is worth understanding because it explains why the product is not a simple commodity. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

On results, here is what the main trial reported. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result, and they apply to the licensed product taken as directed, not to a vial of unknown contents.

Pace matters as much as the headline figure. Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month. Think in months, not days, and judge progress by trend, not individual weigh-ins. Your prescriber reviews your response: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, they will discuss whether continuing or stopping is right for you.¹

The early weeks vary widely. Some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal. Early loss includes water weight, so the trend matters more than any single weigh-in.

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other.¹ Rules like these are built around the licensed pen and dose, and they cannot be applied reliably to a product whose strength you do not know.

10 · Storage and travel

Storage and travel: why the cold chain matters

Mounjaro pens must be kept in a fridge at 2–8°C and never frozen. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, which is useful for short trips, after which it should be discarded. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

This is one of the quieter reasons grey supply is risky. A peptide medicine is sensitive to temperature, and the licensed product comes with defined storage rules built on testing. A vial that has travelled across borders in unknown conditions, perhaps sitting in a warm warehouse or a courier van, has no such history. You cannot see heat damage, and you cannot test for it at home. Our deliveries use free next-day tracked cold-chain packaging, discreet and temperature-controlled, so the pen reaches you within its intended conditions.

For unopened pens, the rule is simple: store them in the fridge until first use, and they keep until the expiry date printed on the box. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit. Figures circulating online often come from other countries' labels, which is exactly how people end up following the wrong advice.¹

Travel is straightforward with a licensed pen. You can fly with Mounjaro. Carry pens in hand luggage, because hold luggage can fall below freezing, ideally in a cool bag with the prescription label or a copy of your prescription. In-use pens tolerate up to 30 days not above 30°C, so most holidays need no special arrangements. For hot climates, use an insulated pouch, and check destination rules for travelling with prescription injectables before you fly.¹

A prescription label is a practical advantage here. It shows security staff and border officials that the medicine was dispensed to you by a pharmacy. A vial with no label, or with a research-chemical label, is far harder to explain and may be confiscated.

When you inject, there is no best time of day. Mounjaro works the same morning or evening, with or without food, and what matters is the same day each week. Many people choose a weekend morning so early side effects fall on days off. You can also change your injection day if at least 3 days have passed since your last dose. Keep it simple, keep the pen cold, and keep the cap on.

If a pen looks damaged, has been frozen or has spent time somewhere unsuitable, do not use it. Contact the pharmacy for advice, and see the leaflet for the product's own handling instructions.¹³

11 · Supplements and alternatives

Supplements, "natural Ozempic" and other alternatives

Is there a natural or cheaper substitute? The honest answer is no. Products marketed as "nature's Ozempic", the "poor man's Ozempic" or a way to "mimic Ozempic naturally" are low-cost supplements sold without any clinical oversight. They are not medicines, are not regulated for this use and have no comparable trial evidence. Marketing that promises dramatic weight-loss claims should be read with caution.

Berberine is the supplement most often given these nicknames. It is available cheaply without assessment, and its dosing is not standardised. If you are taking supplements, tell your prescriber, because some products interact with other medicines or are unsuitable alongside certain conditions.

Fibre, protein-focused eating and regular activity do help appetite and health, and they are part of the plan with any treatment. The licensed medicines are used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹ But diet changes are not a drug substitute, and the nicknames oversell what supplements can do.

On licensed alternatives, there are several. Mounjaro and Wegovy are once-weekly injections. Wegovy's pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after at least four weeks to the 2.4mg maintenance dose. Liraglutide, supplied at 6mg per millilitre, is a daily injection. Tablet options also exist for weight management; see current Wegovy tablet prices on the product page. Your prescriber can explain which fits you, and our Wegovy pen page shows current Wegovy pricing.

You may also see newer combinations discussed online, such as pairing tirzepatide with other compounds. Our pages on tirzepatide and pyridoxine and bimagrumab and tirzepatide explain where those ideas come from and why unlicensed combinations are not something to attempt at home. Medicines in development are not available to buy safely, and anyone selling them is selling something unproven.

As for "the absolute best weight loss pill", no single option is best for everyone. Suitability depends on your health, your goals and how you tolerate each medicine. A free consultation reviewed by a GPhC-registered prescriber is the sensible way to find out. For the wider picture, start with our weight loss clinic overview.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹